Abstract
CHEMOKINES are chemotactic cytokines that activate and direct the migration of leukocytes1,2. There are two subfamilies, the CXC and the CC chemokines. We recently found that the CXC-chemokine stromal cell-derived factor-1 (SDF-1)3,4 is a highly efficacious lymphocyte chemoattractant5. Chemokines act on responsive leukocyte subsets through G-protein-coupled seven-transmembrane receptors1, which are also used by distinct strains of HIV-1 as cofactors for viral entry. Laboratory-adapted and some T-celi-line-tropic (T-tropic) primary viruses use the orphan chemokine receptor LESTR/fusin (also known as fusin)6–8, whereas macrophage-tropic primary HIV-1 isolates use CCR-5 and CCR-3 (refs 7–11), which are receptors for known CC chemokines. Testing of potential receptors demonstrated that SDF-1 signalled through, and hence 'adopted', the orphan receptor LESTR, which we therefore designate CXC-chemokine receptor-4 (CXCR-4). SDF-1 induced an increase in intracellular free Ca2+ and chemotaxis in CXCR-4-transfected cells. Because SDF-1 is a biological ligand for the HIV-1 entry cofactor LESTR, we tested whether it inhibited HIV-1. SDF-1 inhibited infection by T-tropic HIV-1 of HeLa-CD4 cells, CXCR-4 transfectants, and peripheral blood mononuclear cells (PBMCs), but did not affect CCR-5-mediated infection by macrophage-tropic (M-tropic) and dual-tropic primary HIV-1.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Baggiolini, M., Dewald, B. & Moser, B. Adv. Immunol. 55, 97–179 (1994).
Springer, T. A. Annu. Rev. Physiol. 57, 827–872 (1995).
Tashiro, K. et al. Science 261, 600–603 (1993).
Nagasawa, T., Kikutani, H. & Kishimoto, T. Proc. Natl Acad. Sci. USA 91, 2305–2309 (1994).
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A. & Springer, T. A. J. Exp. Med. (in the press).
Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. Science 272, 872–877 (1996).
Choe, H. et al. Cell 85, 1135–1148 (1996).
Doranz, B. J. et al. Cell 85, 1149–1158 (1996).
Dragic, T. et al. Nature 381, 667–673 (1996).
Deng, H. et al. Nature 381, 661–666 (1996).
Alkhatib, G. et al. Science 272, 1955–1958 (1996).
Shirozu, M. et al. Genomics 28, 495–500 (1995).
Roth, S. J., Carr, M. W., Rose, S. S. & Springer, T. A. J. Immunol. Methods 100, 97–116 (1995).
Herzog, H. et al. Proc. Natl Acad. Sci. USA 89, 5794–5798 (1992).
Federsppiel, B. et al. Genomics 16, 707–712 (1993).
Jazin, E. E. et al. Regul. Pept. 47, 247–258 (1993).
Nomura, H., Nielsen, B. W. & Matsushima, K. Int. Immunol. 5, 1239–1249 (1993).
Loetscher, M. et al. J. Biol. Chem. 269, 232–237 (1994).
Helseth, E. et al. J. Virol. 64, 2416–2420 (1990).
Loetscher, M. et al. J. Exp. Med. (in the press).
Nagasawa, T. et al. Nature 382, 635–638.
Rimland, J. et al. Mol. Pharmacol. 40, 869–875 (1991).
Cocchi, F. et al. Science 270, 1811–1815 (1995).
Asjo, B. et al. Lancet (ii), 660–662 (1986).
Schuitemaker, H. et al. J. Virol. 65, 356–363 (1991).
Clark-Lewis, I. et al. Biochem. J. 30, 3128–3135 (1991).
Yenush, L., Kundra, V., White, M. F. & Zetter, B. R. J. Biol. Chem. 269, 100–104 (1994).
Parolin, C., Dorfman, T. Palú, G., Gottlinger, H. & Sodroski, J. J. Virol. 68, 3888–3895 (1994).
Parolin, C., Taddeo, B., Palú, G. & Sodroski, J. Virol. 222, (in the press).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Bleul, C., Farzan, M., Choe, H. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829–833 (1996). https://doi.org/10.1038/382829a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/382829a0
Further reading
-
Let-7f miRNA regulates SDF-1α- and hypoxia-promoted migration of mesenchymal stem cells and attenuates mammary tumor growth upon exosomal release
Cell Death & Disease (2021)
-
Regulation and functional roles of chemokines in liver diseases
Nature Reviews Gastroenterology & Hepatology (2021)
-
A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy
Investigational New Drugs (2021)
-
Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury
Journal of Neuroimmune Pharmacology (2021)
-
A pivotal role for Interferon-α receptor-1 in neuronal injury induced by HIV-1
Journal of Neuroinflammation (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.